{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:28:20Z","timestamp":1794324500013,"version":"4.9.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s10557-026-07925-z","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T08:25:11Z","timestamp":1785918311000},"page":"2209-2240","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lentinan Attenuates Experimental Atherosclerosis by Regulating Macrophage HCK\/GUSB Expression and Amino Acid Metabolic Remodeling"],"prefix":"10.1007","volume":"40","author":[{"given":"Guoling","family":"Rong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaolong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingguang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,5]]},"reference":[{"issue":"7855","key":"7925_CR1","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41586-021-03392-8","volume":"592","author":"P Libby","year":"2021","unstructured":"Libby P. The changing landscape of atherosclerosis. Nature. 2021;592(7855):524\u201333.","journal-title":"Nature"},{"issue":"4","key":"7925_CR2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1161\/CIRCRESAHA.116.308334","volume":"118","author":"P Libby","year":"2016","unstructured":"Libby P, Bornfeldt KE, Tall AR. Atherosclerosis: Successes, Surprises, and Future Challenges. Circ Res. 2016;118(4):531\u20134.","journal-title":"Circ Res"},{"issue":"8","key":"7925_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","volume":"20","author":"O Soehnlein","year":"2021","unstructured":"Soehnlein O, Libby P. Targeting inflammation in atherosclerosis - from experimental insights to the clinic. Nat Rev Drug Discov. 2021;20(8):589\u2013610.","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"7925_CR4","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1056\/NEJMra2000317","volume":"383","author":"R Vergallo","year":"2020","unstructured":"Vergallo R, Crea F. Atherosclerotic Plaque Healing. N Engl J Med. 2020;383(9):846\u201357.","journal-title":"N Engl J Med"},{"key":"7925_CR5","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.atherosclerosis.2016.06.028","volume":"251","author":"P Raggi","year":"2016","unstructured":"Raggi P, Baldassarre D, Day S, de Groot E, Fayad ZA. Non-invasive imaging of atherosclerosis regression with magnetic resonance to guide drug development. Atherosclerosis. 2016;251:476\u201382.","journal-title":"Atherosclerosis"},{"key":"7925_CR6","doi-asserted-by":"crossref","unstructured":"Poznyak A, Grechko AV, Poggio P, Myasoedova VA, Alfieri V, Orekhov AN. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5).","DOI":"10.3390\/ijms21051835"},{"issue":"25","key":"7925_CR7","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","volume":"80","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. J Am Coll Cardiol. 2022;80(25):2361\u201371.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"7925_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/eurjpc\/zwab154","volume":"29","author":"FLJ Visseren","year":"2022","unstructured":"Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, B\u00e4ck M, Benetos A, Biffi A, Boavida JM, Capodanno D, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol. 2022;29(1):5\u2013115.","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"7925_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.118.312782","volume":"124","author":"NC Ward","year":"2019","unstructured":"Ward NC, Watts GF, Eckel RH. Statin Toxicity. Circ Res. 2019;124(2):328\u201350.","journal-title":"Circ Res"},{"issue":"27","key":"7925_CR10","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","volume":"39","author":"F Mach","year":"2018","unstructured":"Mach F, Ray KK, Wiklund O, Corsini A, Catapano AL, Bruckert E, De Backer G, Hegele RA, Hovingh GK, Jacobson TA, et al. Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract. Eur Heart J. 2018;39(27):2526\u201339.","journal-title":"Eur Heart J"},{"issue":"3","key":"7925_CR11","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2018.04.061","volume":"72","author":"OP Ganda","year":"2018","unstructured":"Ganda OP, Bhatt DL, Mason RP, Miller M, Boden WE. Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management. J Am Coll Cardiol. 2018;72(3):330\u201343.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"7925_CR12","first-page":"830","volume":"20","author":"X Cheng","year":"2022","unstructured":"Cheng X, Zhao C, Jin Z, Hu J, Zhang Z, Zhang C. Natural products: potential therapeutic agents for atherosclerosis. Chin J Nat Med. 2022;20(11):830\u201345.","journal-title":"Chin J Nat Med"},{"key":"7925_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.jconrel.2023.02.034","volume":"356","author":"A Kumar","year":"2023","unstructured":"Kumar A, Paliwal R, Gulbake A. Lentinan: An unexplored novel biomaterial in drug and gene delivery applications. J Control Release. 2023;356:316\u201336.","journal-title":"J Control Release"},{"issue":"Pt B","key":"7925_CR14","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1016\/j.ijbiomac.2022.10.024","volume":"222","author":"M Meng","year":"2022","unstructured":"Meng M, Huo R, Wang Y, Ma N, Shi X, Shen X, Chang G. Lentinan inhibits oxidative stress and alleviates LPS-induced inflammation and apoptosis of BMECs by activating the Nrf2 signaling pathway. Int J Biol Macromol. 2022;222(Pt B):2375\u201391.","journal-title":"Int J Biol Macromol"},{"key":"7925_CR15","doi-asserted-by":"publisher","first-page":"136990","DOI":"10.1016\/j.foodchem.2023.136990","volume":"430","author":"D Wang","year":"2024","unstructured":"Wang D, Zhang M, Law CL, Zhang L. Natural deep eutectic solvents for the extraction of lentinan from shiitake mushroom: COSMO-RS screening and ANN-GA optimizing conditions. Food Chem. 2024;430:136990.","journal-title":"Food Chem"},{"key":"7925_CR16","doi-asserted-by":"publisher","first-page":"155965","DOI":"10.1016\/j.phymed.2024.155965","volume":"134","author":"Y Song","year":"2024","unstructured":"Song Y, Chen Y, Cai H, Zhu G, Zeng Y, Abuduxukuer Z, Chen K, Wang J, Ye L, Jin M. Lentinan attenuates allergic airway inflammation and epithelial barrier dysfunction in asthma via inhibition of the PI3K\/AKT\/NF-\u03baB pathway. Phytomedicine. 2024;134:155965.","journal-title":"Phytomedicine"},{"issue":"20","key":"7925_CR17","doi-asserted-by":"publisher","first-page":"4475","DOI":"10.1039\/D3TB00047H","volume":"11","author":"H Wang","year":"2023","unstructured":"Wang H, Gao XD, Yue H. Lentinan-laden microspheres reprogram the tumor microenvironment and improve anti-PD-L1 efficacy. J Mater Chem B. 2023;11(20):4475\u201384.","journal-title":"J Mater Chem B"},{"key":"7925_CR18","doi-asserted-by":"crossref","unstructured":"Cao L, Zhang J, Yu L, Yang W, Qi W, Ren R, Liu Y, Hou Y, Cao Y, Li Q et al. E3 ubiquitin ligase Listerin regulates macrophage cholesterol efflux and atherosclerosis by targeting ABCA1. J Clin Invest. 2025;135(16).","DOI":"10.1172\/JCI186509"},{"key":"7925_CR19","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jare.2024.11.016","volume":"75","author":"T Chu","year":"2025","unstructured":"Chu T, Wang Y, Wang S, Li J, Li Z, Wei Z, Li J, Bian Y. Kaempferol regulating macrophage foaming and atherosclerosis through Piezo1-mediated MAPK\/NF-\u03baB and Nrf2\/HO-1 signaling pathway. J Adv Res. 2025;75:635\u201350.","journal-title":"J Adv Res"},{"issue":"7","key":"7925_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41569-019-0169-2","volume":"16","author":"M B\u00e4ck","year":"2019","unstructured":"B\u00e4ck M, Yurdagul A Jr., Tabas I, \u00d6\u00f6rni K, Kovanen PT. Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities. Nat Rev Cardiol. 2019;16(7):389\u2013406.","journal-title":"Nat Rev Cardiol"},{"key":"7925_CR21","doi-asserted-by":"crossref","unstructured":"Quan W, Sun T, Hu B, Luo Q, Zhong Y, Chen W, Tuo Q. Dipsacoside B attenuates atherosclerosis by promoting autophagy to inhibit macrophage lipid accumulation. Biomolecules. 2024;14(10).","DOI":"10.3390\/biom14101226"},{"issue":"1","key":"7925_CR22","doi-asserted-by":"publisher","first-page":"4297","DOI":"10.1038\/s41467-023-40086-3","volume":"14","author":"M Chen","year":"2023","unstructured":"Chen M, Menon MC, Wang W, Fu J, Yi Z, Sun Z, Liu J, Li Z, Mou L, Banu K, et al. HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy. Nat Commun. 2023;14(1):4297.","journal-title":"Nat Commun"},{"issue":"11","key":"7925_CR23","doi-asserted-by":"publisher","first-page":"e13702","DOI":"10.1111\/cpr.13702","volume":"57","author":"ST Lei","year":"2024","unstructured":"Lei ST, Lai ZZ, Hou SH, Liu YK, Li MQ, Zhao D. Abnormal HCK\/glutamine\/autophagy axis promotes endometriosis development by impairing macrophage phagocytosis. Cell Prolif. 2024;57(11):e13702.","journal-title":"Cell Prolif"},{"issue":"3 Pt 2","key":"7925_CR24","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.fertnstert.2023.03.032","volume":"120","author":"Y Wei","year":"2023","unstructured":"Wei Y, Tan H, Yang R, Yang F, Liu D, Huang B, OuYang L, Lei S, Wang Z, Jiang S, et al. Gut dysbiosis-derived \u03b2-glucuronidase promotes the development of endometriosis. Fertil Steril. 2023;120(3 Pt 2):682\u201394.","journal-title":"Fertil Steril"},{"issue":"4","key":"7925_CR25","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy P, Orecchioni M, Ley K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat Rev Immunol. 2022;22(4):251\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"7925_CR26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41569-024-01072-4","volume":"22","author":"F Bonacina","year":"2025","unstructured":"Bonacina F, Zhang X, Manel N, Yvan-Charvet L, Razani B, Norata GD. Lysosomes in the immunometabolic reprogramming of immune cells in atherosclerosis. Nat Rev Cardiol. 2025;22(3):149\u201364.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"7925_CR27","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.ajpath.2023.12.006","volume":"194","author":"SK Anand","year":"2024","unstructured":"Anand SK, Governale TA, Zhang X, Razani B, Yurdagul A Jr., Pattillo CB, Rom O. Amino Acid Metabolism and Atherosclerotic Cardiovascular Disease. Am J Pathol. 2024;194(4):510\u201324.","journal-title":"Am J Pathol"},{"issue":"3","key":"7925_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/ATVBAHA.118.311572","volume":"39","author":"K Nitz","year":"2019","unstructured":"Nitz K, Lacy M, Atzler D. Amino Acids and Their Metabolism in Atherosclerosis. Arterioscler Thromb Vasc Biol. 2019;39(3):319\u201330.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7925_CR29","doi-asserted-by":"crossref","unstructured":"Wu Y, Avcilar-K\u00fcc\u00fckg\u00f6ze I, Santovito D, Atzler D. Amino acid metabolism and autophagy in atherosclerotic cardiovascular disease. Biomolecules. 2024;14(12).","DOI":"10.3390\/biom14121557"},{"issue":"1","key":"7925_CR30","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1080\/13880209.2024.2415666","volume":"62","author":"J Dai","year":"2024","unstructured":"Dai J, Zhou X, Xu X, Qiu Y, Chen S, Mao W. Study on the anti-atherosclerosis mechanisms of Tanyu Tongzhi formula based on network pharmacology, Mendelian randomization, and experimental verification. Pharm Biol. 2024;62(1):790\u2013802.","journal-title":"Pharm Biol"},{"key":"7925_CR31","doi-asserted-by":"publisher","first-page":"118006","DOI":"10.1016\/j.jep.2024.118006","volume":"327","author":"X Bai","year":"2024","unstructured":"Bai X, Wang S, Shu L, Cao Q, Hu H, Zhu Y, Chen C. Hawthorn leaf flavonoids alleviate the deterioration of atherosclerosis by inhibiting SCAP-SREBP2-LDLR pathway through sPLA2-\u2161A signaling in macrophages in mice. J Ethnopharmacol. 2024;327:118006.","journal-title":"J Ethnopharmacol"},{"issue":"7","key":"7925_CR32","doi-asserted-by":"publisher","first-page":"167927","DOI":"10.1016\/j.bbadis.2025.167927","volume":"1871","author":"J Yang","year":"2025","unstructured":"Yang J, Zhang B, Zhao F, Wang Y, Li B, Dong Y. Ertugliflozin attenuates atherosclerosis in nondiabetic ApoE(-\/-) mice by upregulating ABCA1 and LDLR via the PPAR\u03b3\/LXR\u03b1 pathway. Biochim Biophys Acta Mol Basis Dis. 2025;1871(7):167927.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"8","key":"7925_CR33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ddr.21461","volume":"79","author":"A Nair","year":"2018","unstructured":"Nair A, Morsy MA, Jacob S. Dose translation between laboratory animals and human in preclinical and clinical phases of drug development. Drug Dev Res. 2018;79(8):373\u201382.","journal-title":"Drug Dev Res"},{"issue":"12","key":"7925_CR34","doi-asserted-by":"publisher","first-page":"e5646","DOI":"10.1590\/1414-431x20165646","volume":"49","author":"EL Andrade","year":"2016","unstructured":"Andrade EL, Bento AF, Cavalli J, Oliveira SK, Schwanke RC, Siqueira JM, Freitas CS, Marcon R, Calixto JB. Non-clinical studies in the process of new drug development - Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies. Braz J Med Biol Res. 2016;49(12):e5646.","journal-title":"Braz J Med Biol Res"},{"issue":"Database issue","key":"7925_CR35","doi-asserted-by":"publisher","first-page":"D400","DOI":"10.1093\/nar\/gkr1132","volume":"40","author":"Y Wang","year":"2012","unstructured":"Wang Y, Xiao J, Suzek TO, Zhang J, Wang J, Zhou Z, Han L, Karapetyan K, Dracheva S, Shoemaker BA, et al. PubChem\u2019s BioAssay Database. Nucleic Acids Res. 2012;40(Database issue):D400\u2013412.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"7925_CR36","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","volume":"15","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A, Pratico D, Lin L, Mantzoros CS, Bahijri S, Tuomilehto J, Ren J. Inflammation in atherosclerosis: pathophysiology and mechanisms. Cell Death Dis. 2024;15(11):817.","journal-title":"Cell Death Dis"},{"issue":"10","key":"7925_CR37","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.immuni.2025.09.012","volume":"58","author":"P Libby","year":"2025","unstructured":"Libby P, Soehnlein O. Inflammation in atherosclerosis: Lessons and therapeutic implications. Immunity. 2025;58(10):2383\u2013401.","journal-title":"Immunity"},{"key":"7925_CR38","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ejim.2023.10.013","volume":"120","author":"F Gomez-Delgado","year":"2024","unstructured":"Gomez-Delgado F, Raya-Cruz M, Katsiki N, Delgado-Lista J, Perez-Martinez P. Residual cardiovascular risk: When should we treat it? Eur J Intern Med. 2024;120:17\u201324.","journal-title":"Eur J Intern Med"},{"key":"7925_CR39","doi-asserted-by":"publisher","first-page":"107424842211001","DOI":"10.1177\/10742484221100107","volume":"27","author":"C Coppinger","year":"2022","unstructured":"Coppinger C, Movahed MR, Azemawah V, Peyton L, Gregory J, Hashemzadeh M. A Comprehensive Review of PCSK9 Inhibitors. J Cardiovasc Pharmacol Ther. 2022;27:10742484221100107.","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"9","key":"7925_CR40","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.5551\/jat.RV22038","volume":"32","author":"H Fukami","year":"2025","unstructured":"Fukami H, Oike Y. ANGPTL3: A Breakthrough Target in Treatment for Dyslipidemia and Atherosclerosis. J Atheroscler Thromb. 2025;32(9):1071\u20138.","journal-title":"J Atheroscler Thromb"},{"key":"7925_CR41","doi-asserted-by":"crossref","unstructured":"Yang J, Zhong C, Yu J. Natural monoterpenes as potential therapeutic agents against atherosclerosis. Int J Mol Sci. 2023;24(3).","DOI":"10.3390\/ijms24032429"},{"key":"7925_CR42","doi-asserted-by":"publisher","first-page":"105362","DOI":"10.1016\/j.phrs.2020.105362","volume":"163","author":"X Zhao","year":"2021","unstructured":"Zhao X, Oduro PK, Tong W, Wang Y, Gao X, Wang Q. Therapeutic potential of natural products against atherosclerosis: Targeting on gut microbiota. Pharmacol Res. 2021;163:105362.","journal-title":"Pharmacol Res"},{"issue":"13","key":"7925_CR43","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.124.069574","volume":"151","author":"L Zheng","year":"2025","unstructured":"Zheng L, Chen X, He X, Wei H, Li X, Tan Y, Min J, Chen M, Zhang Y, Dong M, et al. METTL4-Mediated Mitochondrial DNA N6-Methyldeoxyadenosine Promoting Macrophage Inflammation and Atherosclerosis. Circulation. 2025;151(13):946\u201365.","journal-title":"Circulation"},{"issue":"9","key":"7925_CR44","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1038\/s42255-025-01354-2","volume":"7","author":"S Benhmammouch","year":"2025","unstructured":"Benhmammouch S, Borowczyk C, Pierrot-Blanchet C, Barouillet T, Murcy F, Dussaud S, Blanc M, Bl\u00e9riot C, \u00d6rd T, Habbouche L, et al. Slc7a7 licenses macrophage glutaminolysis for restorative functions in atherosclerosis. Nat Metab. 2025;7(9):1924\u201338.","journal-title":"Nat Metab"},{"issue":"13","key":"7925_CR45","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.2174\/0929867322666150209152057","volume":"22","author":"F Musumeci","year":"2015","unstructured":"Musumeci F, Schenone S, Brullo C, Desogus A, Botta L, Tintori C. Hck inhibitors as potential therapeutic agents in cancer and HIV infection. Curr Med Chem. 2015;22(13):1540\u201364.","journal-title":"Curr Med Chem"},{"issue":"17","key":"7925_CR46","doi-asserted-by":"publisher","first-page":"e0047121","DOI":"10.1128\/JVI.00471-21","volume":"95","author":"E Priceputu","year":"2021","unstructured":"Priceputu E, Cool M, Bouchard N, Caceres-Cortes JR, Lowell CA, Hanna Z, Jolicoeur P. HIV-1 Nef Induces Hck\/Lyn-Dependent Expansion of Myeloid-Derived Suppressor Cells Associated with Elevated Interleukin-17\/G-CSF Levels. J Virol. 2021;95(17):e0047121.","journal-title":"J Virol"},{"issue":"11","key":"7925_CR47","doi-asserted-by":"publisher","first-page":"6043","DOI":"10.4049\/jimmunol.1100967","volume":"187","author":"MJ Smolinska","year":"2011","unstructured":"Smolinska MJ, Page TH, Urbaniak AM, Mutch BE, Horwood NJ. Hck tyrosine kinase regulates TLR4-induced TNF and IL-6 production via AP-1. J Immunol. 2011;187(11):6043\u201351.","journal-title":"J Immunol"},{"key":"7925_CR48","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bcp.2017.11.015","volume":"147","author":"J Mitchell","year":"2018","unstructured":"Mitchell J, Kim SJ, Seelmann A, Veit B, Shepard B, Im E, Rhee SH. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal\/Tirap, suppressing LPS-induced inflammatory responses. Biochem Pharmacol. 2018;147:119\u201327.","journal-title":"Biochem Pharmacol"},{"key":"7925_CR49","doi-asserted-by":"publisher","first-page":"155524","DOI":"10.1016\/j.phymed.2024.155524","volume":"128","author":"J Wei","year":"2024","unstructured":"Wei J, Zhang J, Hu F, Zhang W, Wu Y, Liu B, Lu Y, Li L, Han L, Lu C. Anti-psoriasis effect of 18\u03b2-glycyrrhetinic acid by breaking CCL20\/CCR6 axis through its vital active group targeting GUSB\/ATF2 signaling. Phytomedicine. 2024;128:155524.","journal-title":"Phytomedicine"},{"issue":"8","key":"7925_CR50","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/01.ATV.0000134530.27208.41","volume":"24","author":"J Liu","year":"2004","unstructured":"Liu J, Sukhova GK, Sun JS, Xu WH, Libby P, Shi GP. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol. 2004;24(8):1359\u201366.","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07925-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-026-07925-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:02:34Z","timestamp":1794322954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-026-07925-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,5]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["7925"],"URL":"https:\/\/doi.org\/10.1007\/s10557-026-07925-z","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,5]]},"assertion":[{"value":"1 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and agreed to the published version of the manuscript.","order":2,"name":"Ethics","label":"Author Statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}